CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging

Yehezqel Elyahu,Ilana Feygin,Noa Pinkas,Alon Zemer,Amit Shicht,Omer Berner,Ekaterina Eremenko,Anna Nemirovsky,Keren Reshef,Lior Roitman,Valery Krizhanovsky,Alon Monsonego

DOI: https://doi.org/10.1101/2024.01.14.575313

2024-01-15

Abstract:Aging is characterized by the progressive deterioration of tissue structure and function, leading to increased vulnerability to diseases and, eventually, death. One prominent process in aging is the accumulation of senescent cells. Although the immune system has been recognized as crucial for the elimination of senescent cells, the associated mechanisms remain incompletely understood. Here we show that CD4 T cells differentiate into cytotoxic T lymphocytes (CTLs) in a senescent cell-rich environment and that a reduction in the senescent cell load, achieved using chemical senolytic drugs, was sufficient to halt this differentiation. We further demonstrate that eliminating CD4 CTLs in the context of late aging by selectively deleting the Eomes transcription factor in CD4 T cells resulted in the increased accumulation of senescent cells, profound physical deterioration, and a decreased life span. In liver cirrhosis, a model of localized chronic inflammation, CD4 CTL elimination increased the senescent load and worsened the disease. Collectively, our findings demonstrate the fundamental role of CD4 CTLs in modulating tissue senescence and unveil a new aspect of age-related T-cell biology implicated in disease susceptibility and longevity.

Immunology

What problem does this paper attempt to address?

The problem this paper attempts to address is: **How do CD4 T cells acquire cytotoxic properties during aging to regulate cellular senescence and delay the aging process**.

Specifically, the authors focus on how CD4 T cells differentiate into cytotoxic T lymphocytes (CTLs) in an environment rich in senescent cells (SCs), and the impact of this differentiation on aging-related diseases. The paper reveals several key points through experiments:

1. **Mechanism of CD4 CTL differentiation**: The study found that in an environment rich in senescent cells, CD4 T cells can differentiate into CD4 CTLs. This differentiation is regulated by the transcription factor Eomes and can be prevented by reducing the senescent cell burden through chemical drugs (such as senolytic drugs).

2. **Functional role of CD4 CTLs**: In aged mice, specific deletion of the Eomes transcription factor in CD4 T cells leads to a reduction in CD4 CTLs, resulting in the accumulation of senescent cells, significant decline in physical function, and shortened lifespan. This indicates that CD4 CTLs play an important role in clearing senescent cells and maintaining tissue homeostasis.

3. **Role in local chronic inflammation models**: In a cirrhosis model, the elimination of CD4 CTLs increased the burden of senescent cells and exacerbated disease progression. This further demonstrates the importance of CD4 CTLs under chronic inflammatory conditions.

4. **Potential therapeutic significance**: These findings provide new insights for developing immunotherapies targeting aging-related diseases, particularly by enhancing or restoring the function of CD4 CTLs to delay aging and improve health.

In summary, this paper aims to explore the role of CD4 CTLs in the aging process and their potential clinical application value.